Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 61, Issue 8, 2014, Pages 1411-1415

  Offenmüller, Sonja ^a   Ravindranath, Yadddanapudi ^b   Goyette, Gerard ^b   Kanakapalli, Deepa ^b   Miller, Kathryn S ^b   Brecht, Ines B ^a,b   Zolk, Oliver ^c,d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Candidate gene association study; Childhood acute lymphoblastic leukemia; ERCC2; MSR1; PPP1R13L

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER SCREENING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

CANDIDATE GENE ASSOCIATION STUDY; CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA; ERCC2; MSR1; PPP1R13L;

3' UNTRANSLATED REGIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES;

EID: 84901997714     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25011     Document Type: Article

References (43)

1. Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol 2011; 29:551-565.
2. Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest 2012; 122:3407-3415.
3. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41:1006-1010.
4. Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009; 41:1001-1005.
5. Han S, Lee KM, Park SK, et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leukemia Res 2010; 34:1271-1274.
6. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010; 42:492-494.
7. Ellinghaus E, Stanulla M, Richter G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 2012; 26:902-909.
8. Enciso-Mora V, Hosking FJ, Sheridan E, et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 2012; 26:2212-2215.
9. Wesolowska A, Dalgaard MD, Borst L, et al. Cost-effective multiplexing before capture allows screening of 25, 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia 2011; 25:1001-1006.
10. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucl Acid Res 2006; 34:D617-D621.
11. Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 2010; 95:1405-1414.
12. Trenk D, Hochholzer W, Fromm MF, et al. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement. Circ Cardiovasc Genet 2011; 4:429-436.
13. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
14. Dupont WD, Plummer WD, Jr. Power and sample size calculations. A review and computer program. Controlled Clin Trials 1990; 11:116-128.
15. Wang L, Yin F, Xu X, et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: A meta-analysis. PLoS ONE 2012; 7:e34897.
16. Urayama KY, Chokkalingam AP, Manabe A, et al. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol 2013; 97:3-19.
17. Wang H, Wang J, Zhao L, et al. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet 2012; 13:77.
18. de Jonge R, Tissing WJ, Hooijberg JH, et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009; 113:2284-2289.
19. Chen J, Pande M, Huang YJ, et al. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: A large-scale study in non-Hispanic white patients. Carcinogenesis 2013; 34:299-306.
20. Barwick BG, Abramovitz M, Kodani M, et al. Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts. Br J Cancer 2010; 102:570-576.
21. Gillotin S, iASPP, a potential drug target in cancer therapy. Leukemia Res 2009; 33:1175-1177.
22. Laska MJ, Vogel UB, Jensen UB, et al. p53 and PPP1R13L (alias iASPP or RAI) form a feedback loop to regulate genotoxic stress responses. Biochim Biophys Acta 2010; 1800:1231-1240.
23. Yin J, Guo L, Wang C, et al. Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women. Gene 2013; 524:228-231.
24. Pinto EM, Musolino NR, Cescato VA, et al. iASPP: A novel protein involved in pituitary tumorigenesis? Front Horm Res 2010; 38:70-76.
25. Zhang X, Wang M, Zhou C, et al. The expression of iASPP in acute leukemias. Leukemia Res 2005; 29:179-183.
26. Wang F, Chang D, Hu FL, et al. DNA repair gene XPD polymorphisms and cancer risk: A meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev 2008; 17:507-517.
27. Popp HD, Bohlander SK. Genetic instability in inherited and sporadic leukemias. Genes Chromosome Cancer 2010; 49:1071-1081.
28. Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004; 104:3872-3877.
29. Hernandez-Boluda JC, Pereira A, Cervantes F, et al. A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Blood 2012; 119:5221-5228.
30. Susini MC, Guglielmelli P, Spolverini A, et al. The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. Br J Haematol 2013; 162:424-427.
31. Poletto V, Villani L, Catarsi P, et al. No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis. Haematologica 2013; 98:e83-84.
32. Ganster C, Neesen J, Zehetmayer S, et al. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia. Genes Chromosome Cancer 2009; 48:760-767.
33. Chokkalingam AP, Bartley K, Wiemels JL, et al. Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Cause Control 2011; 22:1721-1730.
34. Batar B, Guven M, Baris S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leukemia Res 2009; 33:759-763.
35. Pakakasama S, Sirirat T, Kanchanachumpol S, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 48:16-20.
36. Alvarez-Cubero MJ, Saiz M, Martinez-Gonzalez LJ, et al. Genetic analysis of the principal genes related to prostate cancer: A review. Urol Oncol 2013; 31:1419-1429.
37. Sun J, Hsu FC, Turner AR, et al. Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk. Prostate 2006; 66:728-737.
38. Chen Y, Sullivan C, Peng C, et al. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia. Blood 2011; 118:390-400.
39. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Canc Inst 2013; 105:733-742.
40. Seimon TA, Obstfeld A, Moore KJ, et al. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A 2006; 103:19794-19799.
41. Tanaka T, Akira S, Yoshida K, et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80:353-361.
42. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997; 16:68-73.
43. Schutz FA, Pomerantz MM, Gray KP, et al. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: A cohort study. Lancet Oncol 2013; 14:81-87.